The estimated Net Worth of Richard C Breeden is at least $18.2 Milione dollars as of 21 May 2024. Mr. Breeden owns over 4,584 units of Steris Plc stock worth over $7,880,021 and over the last 17 years he sold STE stock worth over $10,012,296. In addition, he makes $304,850 as Independent Director at Steris Plc.
Richard has made over 10 trades of the Steris Plc stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 4,584 units of STE stock worth $236,214 on 21 May 2024.
The largest trade he's ever made was selling 45,000 units of Steris Plc stock on 24 August 2020 worth over $6,904,350. On average, Richard trades about 2,654 units every 72 days since 2008. As of 21 May 2024 he still owns at least 32,554 units of Steris Plc stock.
You can see the complete history of Mr. Breeden stock trades at the bottom of the page.
Richard C. Breeden serves as Independent Director of the Company. He is also Chairman and Chief Executive Officer of Breeden Capital Management LLC, a registered investment advisor, since 2005. Since 1996 he has also been Chairman of Richard C. Breeden & Co., LLC, a professional services firm providing consulting services. From time to time Mr. Breeden also handles asset distributions to victims of unlawful conduct, typically on behalf of U.S. Government agencies. Since late 2012, Mr. Breeden has served as Special Master on behalf of the U.S. Department of Justice to administer and distribute just over $4 billion in forfeited assets to victims of the fraud at Madoff Securities through the Madoff Victim Fund. Mr. Breeden is currently handling distributions of Fair Funds aggregating over $900 million for the SEC in cases involving British Petroleum’s disclosures involving the oil spill in the Gulf of Mexico, and J.P. Morgan’s disclosures involving the so-called “London Whale,” and a case involving certain mortgage backed securities sold by Citicorp. Mr. Breeden has previously handled asset distributions to victims of unlawful conduct at WorldCom, Enron, Adelphia, Royal Dutch Shell, and other companies. Mr. Breeden served as Chairman of the SEC from 1989 to 1993. Mr. Breeden currently also serves on the Standing Advisory Group of the Public Company Accounting Oversight Board.
As the Independent Director of Steris Plc, the total compensation of Richard Breeden at Steris Plc is $304,850. There are 14 executives at Steris Plc getting paid more, with Walter Rosebrough having the highest compensation of $6,458,640.
Richard Breeden is 70, he's been the Independent Director of Steris Plc since 2008. There are 2 older and 20 younger executives at Steris Plc. The oldest executive at Steris Plc is David Lewis, 76, who is the Independent Director.
Richard's mailing address filed with the SEC is C/O 70 SIR JOHN ROGERSON'S QUAY, , DUBLIN, L2, 2.
Over the last 9 years, insiders at Steris Plc have traded over $157,726,045 worth of Steris Plc stock. The most active insiders traders include Richard Martin Steeves, Walter M Jr Rosebrough e John P Wareham. On average, Steris Plc executives and independent directors trade stock every 19 days with the average trade being worth of $3,374,074. The most recent stock trade was executed by Christopher S Holland on 8 August 2024, trading 473 units of STE stock currently worth $113,369.
steris is a leading provider of infection prevention and procedural surgical products and services, focused primarily on healthcare, pharmaceutical, research and medical device customers. our mission is to provide a healthier today and a safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services. while the corporation was founded as innovative medical technologies in 1985 and renamed steris in 1987, our history dates back to 1894 with the founding of american sterilizer company, a long-time, global leading innovator of sterilization products. today, through a series of strategic acquisitions and continual innovation of new products, steris holds one of the broadest portfolios of products in the industry. it stands at the forefront of efforts to prevent infection and contamination in healthcare, pharmaceutical and medical device environments.
Steris Plc executives and other stock owners filed with the SEC include: